Tranexam Labatec 500 mg/5 mL
Tranexam Labatec 500 mg/5 mL is a medicine authorised by Swissmedic under authorisation number 69390. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 August 2024 and the authorisation is limited until 27 August 2029. ATC code B02AA02 places the medicine in the group Antihemorrhagics.
| Authorisation number | 69390 |
|---|---|
| Name | Tranexam Labatec 500 mg/5 mL |
| Full name | Tranexam Labatec 500 mg/5 mL, solution injectable |
| Authorisation holder | Labatec Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B02AA02 |
| First authorisation | 28 August 2024 |
| Authorisation validity | 27 August 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tranexam Labatec 500 mg/5 mL, solution injectable | B | 28 August 2024 |
| 2 | Tranexam Labatec 1000 mg/10 mL, solution injectable | B | 28 August 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 | Ampulle(n) | B02AA02 | 06.06.0. | B |
| 2 | 5 | Ampulle(n) | B02AA02 | 06.06.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tranexam Labatec 500 mg/5 mL authorised in Switzerland?
Yes. Tranexam Labatec 500 mg/5 mL is authorised by Swissmedic under authorisation number 69390, data as of 01 September 2026. The authorisation is limited until 27 August 2029.
Which dispensing category does Tranexam Labatec 500 mg/5 mL have?
Tranexam Labatec 500 mg/5 mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Tranexam Labatec 500 mg/5 mL?
The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.